Telmitar (Telmisartan)

Telmisartan is a long‑acting angiotensin II receptor blocker (ARB) widely used to manage hypertension and reduce cardiovascular risk. By blocking the AT₁ receptor, telmisartan relaxes blood vessels, lowers systemic vascular resistance, and helps maintain stable blood pressure throughout the day. It is distinguished by one of the longest half‑lives among ARBs, making it ideal for patients who require consistent, round‑the‑clock control. Telmisartan is also approved for reducing cardiovascular morbidity in high‑risk patients who cannot take ACE inhibitors. Its metabolic profile is favorable, with mild PPAR‑γ agonist activity that may offer additional benefits in insulin resistance. Telmisartan is well tolerated, effective as monotherapy or in combination with other antihypertensives, and widely recommended in hypertension guidelines.